HM PAYSON & CO - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
HM PAYSON & CO ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$7,0000.0%3,2520.0%0.00%
Q4 2020$7,000
-22.2%
3,2520.0%0.00%
Q3 2020$9,000
-10.0%
3,2520.0%0.00%
Q2 2020$10,000
+66.7%
3,2520.0%0.00%
Q1 2020$6,000
-33.3%
3,2520.0%0.00%
Q4 2019$9,000
-25.0%
3,2520.0%0.00%
Q3 2019$12,000
-7.7%
3,2520.0%0.00%
Q2 2019$13,0003,2520.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders